![James Cummings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 261 714 $ al 30/06/2026
Dr. James F.
Cummings, MD, is a Chief Medical Officer at Vaxart, Inc. Dr. Cummings was previously employed as a President & Chief Executive Officer by ICON Government & Public Health Solutions, Inc., a VP-Clinical Development & Translational Medicine by Novavax, Inc., a Director-Defense Department by Global Emerging Infectious Surveillance & Response System, and a Director-Translational Medicine by Walter Reed Army Institute of Research.
He also served on the board at OyaGen, Inc. He received his undergraduate degree from Georgetown University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VAXART, INC. 0,18 % | 26/05/2026 | 432.585 ( 0,18 % ) | 261 714 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| VAXART, INC. | Director Técnico/Científico/I+D | 27/09/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
ICON Government & Public Health Solutions, Inc.
 ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Director Ejecutivo | 01/09/2021 |
| NOVAVAX, INC. | Director Técnico/Científico/I+D | 01/01/2018 |
Global Emerging Infectious Surveillance & Response System | Corporate Officer/Principal | 01/08/2015 |
Walter Reed Army Institute of Research | Corporate Officer/Principal | 01/03/2009 |
OyaGen, Inc.
 OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 7 |
|---|---|
Novavax, Inc.
 Novavax, Inc. BiotechnologyHealth Technology Engages in development of novel recombinant vaccines | Health Technology |
OyaGen, Inc.
OyaGen, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical therapies | Health Technology |
ICON Government & Public Health Solutions, Inc.
ICON Government & Public Health Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research solutions | Commercial Services |
Walter Reed Army Institute of Research | |
Georgetown University School of Medicine
 Georgetown University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Global Emerging Infectious Surveillance & Response System |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
